Presenter: Paul Anderson, NMD

Original Date: September 24, 2017

The purpose of this presentation is to allow the attendee a chance to “catch up” after a full day of genomic presentations and get an introduction to the day’s material. Dr. Anderson presents several case studies on patients he has managed. A “1-2-3” approach will be presented which outlines how practitioners can “troubleshoot” the treatment issues that happen when either the patient “self-treats” or has an unusual reaction to a nutrigenomic therapy.

Pharmaceuticals discussed in case presentations will include Deplin, Metanx, Buproprion, and Diphenhydramine.

0.5 Pharmacology, 1.0 General (Total 1.5 CEUs) approved by OBNM